Almirall
Pharmaceutical company
ALM Barcelona Stock Exchange
ISIN ES0157097017 LEI 95980020140005007996
Follow Almirall
Weekly email: filings, results
Revenue, last year
€1.1B
+12.4% vs prior year
Net income
€46.2M
+354.9% vs prior year
EPS, diluted
€0.22
+340% vs prior year
Operating cash flow
€174.5M
+8.5% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €1.1B | €46.2M |
| FY24 | €985.7M | €10.1M |
| FY23 | €894.5M | −€38.5M |
| FY22 | €863.2M | €4.3M |
| FY21 | €827.2M | −€40.9M |
| FY20 | €807.4M | €74.3M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 6.6% | 4.2% |
| FY24 | 3.7% | 1% |
| FY23 | −0.6% | −4.3% |
| FY22 | 5.4% | 0.5% |
| FY21 | 0.7% | −4.9% |
| FY20 | 11.4% | 9.2% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | €139.5M |
| FY24 | €130.9M |
| FY23 | €60M |
| FY22 | €132.1M |
| FY21 | €215M |
| FY20 | €100.9M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | €26.2M | €1.3M |
| FY24 | €3.3M | €539K |
| FY23 | €2.6M | €157K |
| FY22 | €12.4M | €46K |
| FY21 | €11.7M | €596K |
| FY20 | €2.1M | €82K |
- Almirall
- Healthcare median
Show the numbers
| Year | Almirall | Healthcare median |
|---|---|---|
| FY25 | 4.2% | −30.6% |
| FY24 | 1% | −47% |
| FY23 | −4.3% | −58% |
| FY22 | 0.5% | −80.4% |
| FY21 | −4.9% | −71.9% |
| FY20 | 9.2% | −62.2% |